Regulatory Compliance

Delray Beach, Fla. – September 21, 2026 -- The global rubber process oil (RPO) market is set to expand from $3.30 billion in 2026 to $3.94 billion by 2031, growing at a compound annual growth rate of 3.6%, according to a new report from MarketsandMarkets.

Tire manufacturing drives largest share of oil demand

The tires application segment is projected to register the highest growth at 4.7% CAGR and remains the largest consumer of RPO by value. Manufacturers rely on process oils to balance flexibility, durability, and processing efficiency across passenger, commercial, and specialty tire production. Rising replacement-tire demand and evolving fuel-efficiency standards are reinforcing this consumption base.

Kunshan – September 21, 2026 -- Arctech has been awarded a Silver Medal in the 2026 EcoVadis Sustainability Rating, placing the solar tracker maker among the top 15% of companies assessed by EcoVadis worldwide.

EcoVadis scores companies across four sustainability pillars

The rating agency evaluates firms on Environment, Labor & Human Rights, Ethics, and Sustainable Procurement, ranking medal recipients by percentile against all companies assessed globally over the prior 12 months. Arctech's Silver Medal corresponds to the top 15% tier.

Arctech spent RMB 4.3629 million on environmental protection in 2025

That figure, approximately US$651,000, funded initiatives tied to the company's environmental performance improvements. Its self-owned photovoltaic power stations generated more than 34 million kWh of electricity, covering 24% of Arctech's total electricity consumption.

Aachen, Germany – September 21, 2026 -- Grünenthal has agreed to acquire Bayer AG's oncology drug Stivarga® (regorafenib) for up to €375 million, adding an oral cancer treatment sold in more than 90 markets to its portfolio.

Grünenthal expects Stivarga to add up to €100 million to EBITDA in 2027

The German pharmaceutical company said the acquisition is immediately accretive to its business, with an estimated positive impact on consolidated EBITDA of approximately €100 million for the year ending December 31, 2027. That projection assumes the deal closes by the end of 2026 or early 2027 and includes a full year of consolidation.

Stockholm – September 21, 2026 -- Telefonaktiebolaget LM Ericsson repurchased Class B shares between September 14 and September 18, 2026, under its ongoing SEK 15,000,000,000 buyback program, lifting the company's treasury stock holding to 108,018,663 Class B shares.

Ericsson's buyback program targets up to SEK 15 billion through March 2027

The repurchase activity forms part of a program Ericsson announced on April 16, 2026, running from April 23, 2026, through March 31, 2027 at the latest. The initiative is structured under the EU's Market Abuse Regulation (No 596/2014) and the accompanying Safe Harbour Regulation (Commission Delegated Regulation (EU) 2016/1052 of March 8, 2016), ensuring the transactions comply with European market conduct rules.

Boston – September 21, 2026 -- Global M&A value climbed 15% year over year in the first eight months of 2026, exceeding the ten-year average by 11%, according to a new report from Boston Consulting Group (BCG). The number of megadeals worth $10 billion or more rose to 37 from 24 a year earlier, surpassing 2021's record of 32.

Megadeal surge masks a narrower recovery below the top of the market

Transactions valued at $1 billion or more are running above longer-term norms, but deal volume for small-cap and midcap transactions remains below historical levels even before inflation adjustments. BCG's M&A Sentiment Index rose to 83 from 79 at the start of the year, still well below its long-term average of 100.

London and St Helier, Jersey – September 21, 2026 -- Bloomsbury Money Group has appointed Thomas Holst, a former SAP health-technology engineer with more than a decade of experience, as Chief Technology Officer to lead the build-out of its multi-jurisdiction banking platform.

Holst will unify fiat, digital assets and payment rails onto one platform

Holst joins from SAP's health technology ecosystem in Germany, where he spent 13 years building data-intensive, privacy-critical software for hospitals and research institutions and the cloud infrastructure supporting it. At Bloomsbury Money, he will oversee technology strategy, engineering and platform architecture as the group consolidates its multi-currency accounts, foreign exchange, cross-border payments and regulated virtual asset services onto a single infrastructure designed to operate under one standard of control across multiple regulatory regimes.

New Taipei City – September 21, 2026 -- UD info's DB Series SSD Drives have achieved FIPS 140-3 validation from the National Institute of Standards and Technology's Cryptographic Module Validation Program, with NIST Certificate No. 5479 issued August 12, 2026, confirming Overall Level 2 status.

Certificate confirms Overall Level 2 validation for DB Series cryptographic module

The validation provides independent third-party assurance that the DB Series meets federal cryptographic security requirements, addressing procurement mandates in government, critical infrastructure, and other regulated sectors. NIST CMVP validation is a common prerequisite for federal and defense-adjacent storage procurement in the United States.

Melbourne – September 21, 2026 -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX) has signed a strategic agreement to merge with ITM Isotope Technologies Munich SE in a deal valuing ITM at US$1.65 billion upfront on a cash-free, debt-free basis, with up to US$700 million in additional contingent consideration tied to regulatory and sales milestones.

Deal structures $1.25 billion in Telix stock alongside debt assumption

Under the agreement, ITM shareholders will receive approximately US$1.25 billion in the form of 105.8 million Telix shares priced at US$11.84 per share, released as Nasdaq-listed ADRs following escrow periods of up to 15 months. Telix will additionally assume US$302 million of ITM net debt at closing, with US$96 million allocated to management equity rollover and transaction expenses. Upon completion, existing Telix shareholders will hold roughly 76.3% of the combined company, with ITM shareholders holding approximately 23.7%.

Seattle – September 21, 2026 -- Convera and JustLogin have partnered to embed regulated cross-border payroll and business payment capabilities directly into JustLogin's HR platform, enabling companies to initiate payments in up to 16 currencies across Singapore and Southeast Asia.

Partnership targets $105 billion regional B2B payments opportunity

Southeast Asia's B2B payments market was valued at approximately USD 44.5 billion in 2024 and is projected to exceed USD 105 billion by 2033, according to figures cited by the companies. The integration positions JustLogin's HR platform to capture a share of that growth by letting customers manage payroll disbursement without leaving their existing workflow.

Shanghai – September 21, 2026 -- Antengene Corporation Limited (SEHK: 6996.HK) has dosed the first patient in China in its pivotal Phase III CLINCH-3 study evaluating ATG-022, a CLDN18.2 antibody-drug conjugate, as monotherapy for CLDN18.2-positive advanced gastric or gastroesophageal junction adenocarcinoma.

Breakthrough Therapy Designation accelerated the trial's launch

China's National Medical Products Administration granted ATG-022 Breakthrough Therapy Designation, which the company says streamlined regulatory communications and enabled the rapid start of CLINCH-3. The randomized, controlled, open-label multicenter study is initiated in China and planned for expansion into a multi-regional clinical trial, with Professor Lin Shen of Peking University Cancer Hospital serving as principal investigator. The study compares ATG-022 against treatment of investigator's choice, targeting a future marketing approval application.